Target intelligence / Profile preview

Low affinity immunoglobulin gamma Fc region receptor II-c (FCGR2C)

Target
FCGR2C
Molecular classification
Receptor, Transmembrane signaling receptor, Immunoglobulin superfamily member
01

Overview

Low affinity immunoglobulin gamma Fc region receptor II-c (FCGR2C) is a transmembrane protein found primarily on the surface of various immune cells. It acts as a low-affinity receptor for the Fc portion of complexed immunoglobulins gamma (IgG), mediating several key effector functions such as phagocytosis, regulation/modulation of antibody production by B cells, and signal transduction during an immune response. The gene encoding this protein belongs to a cluster that includes other closely related receptors like FCGR2A and FCGR2B; all are part of the broader CD32 family. Variants in these genes can influence susceptibility to autoimmune diseases such as systemic lupus erythematosus. Due to its role in modulating immunity—both activating and inhibitory—FCGR2C is considered a potential therapeutic target in autoimmunity, infection control, cancer therapy using monoclonal antibodies, and other conditions where antibody-mediated immunity plays a central role.

Other names
CD32cFc-gamma RII-cFc-gamma-RIIcFCG2CFcRII-cIGFR2
02

Mechanism of action

Drugs targeting this molecule generally act via one or more of the following mechanisms: - Antibody-dependent cellular cytotoxicity through engagement with the Fc region on therapeutic antibodies. - Modulation of phagocytosis and clearance of immune complexes. - Downregulation or upregulation of B cell activity depending on context and isoform.

03

Biological functions

Immune response (mediates effector and regulatory functions)Signal transduction (transmembrane signaling)Phagocytosis of immune complexesModulation of antibody production by B cells
04

Disease associations

Autoimmune disease (e.g., systemic lupus erythematosus, rheumatoid arthritis)Infection (role in immune defense)
05

Safety considerations

Potential safety concerns include increased risk for infections due to modulation/suppression of normal immune responsespossible exacerbation or induction of autoimmunity if inhibitory function is lostoff-target effects due to high similarity among CD32 family members
06

Interacting drugs

Human immunoglobulin G

4 more in the full profile.

07

Biomarkers

No specific biomarkers for patient selection are directly listed for FCGR2C; however, expression levels and genetic variants in related receptors such as FCGR2B have been associated with autoimmune disease risk and may serve as indirect biomarkers.

Beyond the preview

Go deeper on Low affinity immunoglobulin gamma Fc region receptor II-c (FCGR2C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Low affinity immunoglobulin gamma Fc region receptor II-c (FCGR2C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call